recurrent adult diffuse large cell lymphoma

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

Active, not recruiting
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +9 more
  • BTK inhibitor PCI-32765
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 27, 2022

Prolymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Columbus, Salt

Active, not recruiting
  • Prolymphocytic Leukemia
  • +4 more
  • Columbus, Ohio
  • +1 more
Apr 29, 2022

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma Trial in Atlanta, Columbus (drug, biological, other)

Terminated
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +10 more
  • Atlanta, Georgia
  • +1 more
May 3, 2018

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Terminated
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +27 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 27, 2016

Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, MALT Trial in Columbus (gemcitabine HCl, triapine)

Completed
  • Anaplastic Large Cell Lymphoma
  • +58 more
  • Columbus, Ohio
    Ohio State University Medical Center
Sep 27, 2013

B-cell Adult Acute Lymphoblastic Leukemia, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Columbus (rituximab, aldesleukin,

Completed
  • B-cell Adult Acute Lymphoblastic Leukemia
  • +52 more
  • rituximab
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 5, 2013

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Columbus

Terminated
  • Adult Acute Basophilic Leukemia
  • +34 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013